Individualized and effective outpatient treatment


IAA's Interior Medication Assisted Treatment offers professional assessment, treatment planning, and evidence-based individual and group counseling, case management and education to help individuals struggling with opioid addiction make meaningful and sustainable changes in their lives. These changes will positively impact their relationships with the community (e.g., gaining employment, decreasing recidivism, reuniting with children and family).




About Medication-Assisted Treatment


"Medication-assisted treatment (MAT) for opioid addiction uses drugs (medication) to stabilize brain chemistry, reduce or block the euphoric effects of opioids, relieve physiological cravings and normalize body functions.


There are three drugs (medications) approved by the FDA for the treatment of opioid addiction: buprenorphine, methadone and naltrexone. All three of these treatments have been demonstrated to be safe and effective in combination with counseling and psychosocial support.


Everyone who seeks treatment for an opioid use disorder should be offered access to all three options. This allows providers to work with patients to select the treatment best suited to a patient’s individual needs." (FDA Statement, 11/30/17)


IMAT includes each of these medications along with substance abuse counseling, education and case management. 

Who Is Eligible?


· People who have been addicted to heroin or other opiates for more than one year who have been unable to stop using on their own.


· Pregnant women and injection drug users are given priority in admissions.


IMAT provides services that prevent death, disease, misery, crime, incarceration and removal of children from parental custody. These services also improve physical and mental health, relationships, parenting, relapse prevention, education, employment, financial security, community involvement, personal resilience and life satisfaction.


The overall goal of the project is to assist individuals to regain or establish the control necessary to build and maintain an informed, productive and dependency-free lifestyle.

How to Apply


1. Print out an application here. Or pick up an application packet at 710 3rd Avenue in downtown Fairbanks from 9 am – 4 pm, Mon – Fri. You can also have an application mailed or emailed to you by calling (907) 452-4222 x 100.


2. Complete the application and return it to IAA. A staff member will review it with you.


3. You will be called with an assessment appointment with a certified, master's level substance abuse counselor.


4. Your information will be evaluated by the treatment team for appropieateness for medication-assisted treatment.


5. A case manager will contact you to assist you with the necessary paperwork and lab work.


6. Once you have completed these steps, the Medical Director will schedule your admission.


Call (907) 452-4222 ext. 100 for more information. 

Types of Medication Offered by IMAT:


Methadone is a synthetic opioid used for more than 50 years to treat heroin and opioid addiction. Methadone fills opioid receptors, relieving withdrawals and cravings.


Methadone lessens the painful symptoms of opiate withdrawal and blocks the euphoric effects of opiate drugs such as heroin, morphine, and codeine, as well as semi-synthetic opioids like oxycodone and hydrocodone.


When taken as prescribed, it is safe and effective. It allows people to recover from their addiction and to reclaim active and meaningful lives.


Buprenorphine (Suboxone)

Buprenorphine, also known by its brand-names: Suboxone, Subutex, and others; is now available in our treatment program. Like methadone, buprenorphine binds to opioid receptors, relieving withdrawal symptoms and reducing cravings for opioids like heroin.


Buprenorphine has unique pharmacological properties that help:


- Lower the potential for misuse

- Diminish the effects of physical dependency, such as withdrawal symptoms and cravings

- Increase safety in cases of overdose


Buprenorphine’s opioid effects increase with each dose until at moderate doses they level off, even with further dose increases. This “ceiling effect” lowers the risk of misuse, dependency, and side effects.


Medications such as buprenorphine, in combination with counseling and behavioral therapies, provide a whole-patient approach to the treatment of opioid dependency. When taken as prescribed, buprenorphine is safe and effective.

Naltrexone (Vivitrol)

Vivitrol is a time-release, injectable form of the drug Naltrexone, a medication approved by the Food and Drug Administration (FDA) to treat opioid use disorders and alcohol use disorders.


Vivitrol blocks opioid drugs from binding to receptors for about 28 days.


Naltrexone blocks the euphoric and sedative effects of drugs such as heroin, morphine, and codeine. It works differently in the body than buprenorphine and methadone, which activate opioid receptors in the body that suppress cravings.


Naltrexone binds and blocks opioid receptors, and is reported to reduce opioid cravings. There is no abuse and diversion potential with naltrexone.


As with all medications used in medication-assisted treatment (MAT), naltrexone is used as part of a comprehensive treatment plan that includes counseling and participation in social support programs.

Recovery is Possible

The American Society of Addiction Medicine’s definition of addiction concludes that “treatment of addition saves lives,” and it points out that “in some cases of addiction, medication management can improve treatment outcomes.”


“In most cases of addiction, the integration of psychosocial rehabilitation and ongoing care with evidence-based pharmacological therapy provides the best results.”


Ready to get started? Print out an application here. Or pick up an application packet at 710 3rd Avenue in downtown Fairbanks. You can also have an application mailed or emailed to you by calling (907) 452-4222 x 100.


Print Print | Sitemap
© Interior AIDS Association